This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kymab Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jacob Galson: Innovator in Immunotherapy
Introduction
Jacob Galson is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on antibodies. His research focuses on enhancing the immune response in patients, especially in the context of cancer treatment.
Latest Patents
Jacob Galson holds a patent for "Antibodies to ICOS," which involves antibodies that bind to the Inducible T cell Co-Stimulator (ICOS). This patent outlines the therapeutic use of anti-ICOS antibodies for modulating the ratio between regulatory T cells and effector T cells. The goal is to stimulate the immune system of patients, including applications in treating various cancers. Additionally, the patent discusses combinations of anti-ICOS antibodies with other drugs for immuno-oncology.
Career Highlights
Jacob Galson is associated with Kymab Limited, a company dedicated to advancing therapeutic solutions through innovative antibody technologies. His work at Kymab has positioned him as a key player in the development of novel immunotherapies.
Collaborations
Jacob collaborates with talented individuals such as Aksana Labokha and Nahida Parveen, contributing to a dynamic research environment focused on cutting-edge immunological advancements.
Conclusion
Jacob Galson's contributions to the field of immunotherapy through his patent on anti-ICOS antibodies exemplify his commitment to enhancing cancer treatment options. His work continues to inspire advancements in the medical field.